China case shows war on drug costs in emerging markets10:16am EDTBy Ben Hirschler, Adam Jourdan and Lavinia MoLONDON/HONG KONG (Reuters) – International drugmakers are under fire in emerging markets as governments crack down on high prices and corporate malpractice, raising a risk to the price premiums global players enjoy over local rivals.China’s probe into pricing by 60 firms, including local units of multinationals, and its dramatic charge against GlaxoSmithKline Plc of widespread bribery to boost sales and prices are the latest salvos.The trend casts a shadow over emerging markets as key growth drivers for Western drugmakers as blockbust here
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Saturday, July 13, 2013
China case shows war on drug costs in emerging markets
China case shows war on drug costs in emerging markets10:16am EDTBy Ben Hirschler, Adam Jourdan and Lavinia MoLONDON/HONG KONG (Reuters) – International drugmakers are under fire in emerging markets as governments crack down on high prices and corporate malpractice, raising a risk to the price premiums global players enjoy over local rivals.China’s probe into pricing by 60 firms, including local units of multinationals, and its dramatic charge against GlaxoSmithKline Plc of widespread bribery to boost sales and prices are the latest salvos.The trend casts a shadow over emerging markets as key growth drivers for Western drugmakers as blockbust here
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment